Form 13-F position report

ELECTRA THERAPEUTICS INC COM

Reported by EcoR1 Capital LLC

ETRA CUSIP 284825106 Manager CIK 0001587114

First reported at 1,700,000 shares this quarter.

New
% of reported 13F value 0.85% This manager · Q3 2026
Shares 1,700,000 Quarter-end amount reported
Reported value $19,125,000 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 19125000

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for ELECTRA THERAPEUTICS INC COM held by EcoR1 Capital LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 1,700,000 +1,700,000 (0.0%) 0.85% $19,125,000 2026-11-16

Who else reported the position

59 managers reported ELECTRA THERAPEUTICS INC COM for Q3 2026.

Managers reporting ELECTRA THERAPEUTICS INC COM in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ORBIMED ADVISORS LLC New 6,885,170 +6,885,170 1.41% $77,458,163 1 qtr
Redmile Group LLC New 5,430,918 +5,430,918 4.47% $61,097,828 1 qtr
EQT Fund Management S a r l New 3,795,281 +3,795,281 4.51% $42,696,911 1 qtr
Cormorant Asset Management LP New 3,365,533 +3,365,533 2.54% $37,862,249 1 qtr
Nextech Invest Ltd New 2,636,225 +2,636,225 1.33% $29,657,531 1 qtr
Blue Owl Capital Holdings LP New 2,611,143 +2,611,143 5.36% $29,375,359 1 qtr
Sanofi New 2,461,948 +2,461,948 4.4% $27,696,915 1 qtr
JEFFERIES FINANCIAL GROUP INC New 2,244,333 +2,244,333 0.19% $25,248,746 1 qtr
JPMorgan Chase & Co New 2,095,670 +2,095,670 < 0.01% $23,785,854 1 qtr
MIC Capital Management UK LLP New 1,977,170 +1,977,170 4.8% $22,243,163 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM ADDED

Voting authority reported

Sole
1,700,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.